Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KB-707 by Krystal Biotech for Non-Small Cell Lung Cancer: Likelihood of Approval
KB-707 is under clinical development by Krystal Biotech and currently in Phase II for Non-Small Cell Lung Cancer. According to...
KB-707 by Krystal Biotech for Metastatic Melanoma: Likelihood of Approval
KB-707 is under clinical development by Krystal Biotech and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase...
KB-707 by Krystal Biotech for Solid Tumor: Likelihood of Approval
KB-707 is under clinical development by Krystal Biotech and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
KB-408 by Krystal Biotech for Alpha-1 Antitrypsin Deficiency (A1AD): Likelihood of Approval
KB-408 is under clinical development by Krystal Biotech and currently in Phase I for Alpha-1 Antitrypsin Deficiency (A1AD). According to...
Inetagugene geperpavec by Krystal Biotech for Harlequin Ichthyosis (Autosomal Recessive Congenital Ichthyosis 4B): Likelihood of Approval
Inetagugene geperpavec is under clinical development by Krystal Biotech and currently in Phase II for Harlequin Ichthyosis (Autosomal Recessive Congenital...